Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Alembic Pharmaceuticals Limited
Press Release Mar 14 2022
Business
Mar 14 2022
4 min read

Press Release Mar 14 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 14-Mar-2022 titled Alembic Pharmaceuticals receives USFDA Tentative Approval for Macitentan Tablets, 10 mg.

View Attachment